Analyst Downgrades: McDonald's Corporation, ACADIA Pharmaceuticals Inc., and Tesla Motors Inc

Analysts downwardly revised their ratings and price targets on McDonald's Corporation (NYSE:MCD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Tesla Motors Inc (NASDAQ:TSLA)

Jun 22, 2016 at 9:14 AM
facebook X logo linkedin

Analysts are weighing in on Dow stock McDonald's Corporation (NYSE:MCD), biotech ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and automaker Tesla Motors Inc (NASDAQ:TSLA). Here's a quick roundup of today's bearish brokerage notes on MCD, ACAD, and TSLA.

  • MCD is 0.9% lower ahead of the open, after Nomura cut its rating to "neutral" from "buy," while slashing its price target to $129 from $142. This is just the latest bout of pessimism thrown toward the stock, as short interest has been surging, and put buying has nearly doubled call buying during the past two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Still, McDonald's Corporation has gained over 26% in the past 12 months to trade at $122.63, while hitting record highs last month. On the news front, the company has reportedly received multiple bids for its China and Hong Kong stores
  • ACAD has dropped more than 2% in electronic trading, after BofA-Merrill Lynch downgraded the stock to "neutral" from "buy." Shares of ACADIA Pharmaceuticals Inc. dropped over 6% yesterday, likely due to sector-wide headwinds, to close at $34.99 -- back in the red for 2016. If ACAD continues to struggle, it could get hit with more downgrades, since six of seven analysts were calling it a "strong buy" coming into today. 
  • TSLA last night offered to buy fellow Elon Musk firm SolarCity Corp (NASDAQ:SCTY) for roughly $2.8 billion -- or $26.50-$28.50 per SCTY share. Musk has deemed the deal a "no brainer," and said he will recuse himself from the shareholders' vote, which has yet to be scheduled. In the meantime, Wall Street hasn't reacted well, with Tesla Motors Inc set to open 11% lower this morning. Moreover, Oppenheimer cut TSLA to "perform" from "outperform," and removed its price target of $385. Based on last night's close at $219.61, the stock was already well below breakeven on a year-to-date basis, and has lagged the broader S&P 500 Index (SPX) by roughly 13 percentage points in the past two months. Nonetheless, call buying has remained hot.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI